Skip to main content

CORRECTION article

Front. Med., 05 January 2024
Sec. Regulatory Science
Volume 10 - 2023 | https://doi.org/10.3389/fmed.2023.1337712

Corrigendum: Concurrent use of oral anticoagulants and sulfonylureas in individuals with type 2 diabetes and risk of hypoglycemia: a UK population-based cohort study

This article is a correction to:

  1. Concurrent Use of Oral Anticoagulants and Sulfonylureas in Individuals With Type 2 Diabetes and Risk of Hypoglycemia: A UK Population-Based Cohort Study

    1. Read original article
\r\nHassan Alwafi,Hassan Alwafi1,2Ian C. K. Wong,,,,Ian C. K. Wong1,3,4,5,6Abdallah Y. NaserAbdallah Y. Naser7Amitava Banerjee,,Amitava Banerjee8,9,10Pajaree Mongkhon,Pajaree Mongkhon11,12Cate WhittleseaCate Whittlesea1Alaa AlsharifAlaa Alsharif13Li Wei,, Li Wei1,5,6*
  • 1Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom
  • 2Faculty of Medicine, Umm Al Qura University, Mecca, Saudi Arabia
  • 3Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China
  • 4Department of Pharmacy, The University of Hong Kong - Shenzhen Hospital, Shenzhen, China
  • 5Laboratory of Data Discovery for Health, Hong Kong Science Park, Pak Shek Kok, Hong Kong SAR, China
  • 6Centre for Medicines Optimisation Research and Education, University College London Hospitals National Health Service (NHS) Foundation Trust, London, United Kingdom
  • 7Department of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, Amman, Jordan
  • 8Institute of Health Informatics, University College London, London, United Kingdom
  • 9Department of Cardiology, University College London Hospitals NHS Trust, London, United Kingdom
  • 10Department of Cardiology, Barts Health NHS Trust, London, United Kingdom
  • 11Department of Pharmacy Practice, School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand
  • 12Pharmacoepidemiology and Statistics Research Center (PESRC), Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand
  • 13Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia

A corrigendum on
Concurrent use of oral anticoagulants and sulfonylureas in individuals with type 2 diabetes and risk of hypoglycemia: a UK population-based cohort study

by Alwafi, H., Wong, I. C. K., Naser, A. Y., Banerjee, A., Mongkhon, P., Whittlesea, C., Alsharif, A., and Wei, L. (2022). Front. Med. 9:893080. doi: 10.3389/fmed.2022.893080

In the published article, there was a mistake in the affiliation for “Alaa Alsharif.” The affiliation for “Alaa Alsharif” was displayed as “Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom.” The correct affiliation is “Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: oral anticoagulants, hypoglycemia, sulfonylureas, diabetes mellitus, United Kingdom, drug-drug interactions

Citation: Alwafi H, Wong ICK, Naser AY, Banerjee A, Mongkhon P, Whittlesea C, Alsharif A and Wei L (2024) Corrigendum: Concurrent use of oral anticoagulants and sulfonylureas in individuals with type 2 diabetes and risk of hypoglycemia: a UK population-based cohort study. Front. Med. 10:1337712. doi: 10.3389/fmed.2023.1337712

Received: 13 November 2023; Accepted: 18 December 2023;
Published: 05 January 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Alwafi, Wong, Naser, Banerjee, Mongkhon, Whittlesea, Alsharif and Wei. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Li Wei, bC53ZWkmI3gwMDA0MDt1Y2wuYWMudWs=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.